{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:12:14Z","timestamp":1776615134263,"version":"3.51.2"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.dsx.2016.12.042","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T19:01:17Z","timestamp":1482778877000},"page":"S263-S272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Metabolic parameters in diabetic neuropathic patients after treatment with pregabalin"],"prefix":"10.1016","volume":"11","author":[{"given":"O.A.","family":"Abou Zeid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.Y.","family":"Elkhouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.N.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2016.12.042_bib0001","series-title":"IDF DIABETES ATLAS","year":"2013"},{"key":"10.1016\/j.dsx.2016.12.042_bib0002","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0003","doi-asserted-by":"crossref","first-page":"674987","DOI":"10.1155\/2014\/674987","article-title":"Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets","volume":"2014","author":"Sandireddy","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.dsx.2016.12.042_bib0004","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: review and implications","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.dsx.2016.12.042_bib0005","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.2337\/dc13-0382","article-title":"Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study","volume":"36","author":"Herder","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0006","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"Clinical review: the role of advanced glycation end products in progression and complications of diabetes","volume":"93","author":"Goh","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2016.12.042_bib0007","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mus.20785","article-title":"Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms","volume":"36","author":"Zochodne","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.dsx.2016.12.042_bib0008","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.acthis.2007.12.004","article-title":"Epidermal nerve fiber quantification in the assessment of diabetic neuropathy","volume":"110","author":"Beiswenger","year":"2008","journal-title":"Acta Histochem"},{"key":"10.1016\/j.dsx.2016.12.042_bib0009","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0010","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/db08-1771","article-title":"Elevated triglycerides correlate with progression of diabetic neuropathy","volume":"58","author":"Wiggin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2016.12.042_bib0011","first-page":"CD007543","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dsx.2016.12.042_bib0012","first-page":"106","article-title":"Total vascular risk as a strong correlate of severity of diabetic peripheral neuropathy in Nigerian Africans","volume":"22","author":"Owolabi","year":"2012","journal-title":"Ethn Dis"},{"key":"10.1016\/j.dsx.2016.12.042_bib0013","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncpendmet1066","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat Clin Pract End Met"},{"key":"10.1016\/j.dsx.2016.12.042_bib0014","first-page":"467","article-title":"Analysis of the related risk factors of diabetic peripheral neuropathy","volume":"26","author":"Nie","year":"2012","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.dsx.2016.12.042_bib0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1742-1241.2007.01336.x","article-title":"The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys","volume":"61","author":"Bays","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.dsx.2016.12.042_bib0016","first-page":"470","article-title":"Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice","volume":"107","author":"Feller","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.dsx.2016.12.042_bib0017","first-page":"77","article-title":"Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic","volume":"20","author":"Al-Wakeel","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.dsx.2016.12.042_bib0018","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0256-4947.81528","article-title":"Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia","volume":"31","author":"Alwakeel","year":"2011","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0019","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.dsx.2016.12.042_bib0020","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1093\/ndt\/gfi074","article-title":"Evaluation of tests for microalbuminuria screening in patients with diabetes","volume":"20","author":"Incerti","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dsx.2016.12.042_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/dc06-0947","article-title":"Does treatment with duloxetine for neuropathic pain impact glycemic control?","volume":"30","author":"Hardy","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0022","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4103\/IJMR.2010_132_05_531","article-title":"Strategies for initial management of hypertension","volume":"132","author":"Gupta","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.dsx.2016.12.042_bib0023","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajcn\/68.4.899","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults","volume":"68","year":"1998","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.dsx.2016.12.042_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001250051063","article-title":"The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups: neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS)","volume":"41","author":"Cabezas-Cerrato","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2016.12.042_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2016.12.042_bib0026","series-title":"Distal symmetric polyneuropathy: A definition for clinical research Report of the American Academy of Neurology and the American Association of Electrodiagnostic Medicine","author":"England","year":"2005"},{"key":"10.1016\/j.dsx.2016.12.042_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.880110106","article-title":"Detection, characterization, and staging of polyneuropathy: assessed in diabetics","volume":"11","author":"Dyck","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.dsx.2016.12.042_bib0028","first-page":"1163","article-title":"A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain","volume":"11","author":"King","year":"2015","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.dsx.2016.12.042_bib0029","first-page":"372","article-title":"Pharmacological treatment of diabetic peripheral neuropathy","volume":"40","author":"Cohen","year":"2015","journal-title":"Pharm Ther"},{"key":"10.1016\/j.dsx.2016.12.042_bib0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/dmrr.1225","article-title":"Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management","volume":"27","author":"Tesfaye","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2016.12.042_bib0031","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/diacare.22.9.1479","article-title":"Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort","volume":"22","author":"Dyck","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0032","doi-asserted-by":"crossref","first-page":"e106935","DOI":"10.1371\/journal.pone.0106935","article-title":"Prevalence and correlates of diabetic peripheral neuropathy in a saudi arabic population: a cross-Sectional study","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2016.12.042_bib0033","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1464-5491.2008.02397.x","article-title":"Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55)","volume":"25","author":"Pradeepa","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2251-6581-13-62","article-title":"A study of the use of carbamazepine pregabalin and alpha lipoic acid in patients of diabetic neuropathy","volume":"13","author":"Patel","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.dsx.2016.12.042_bib0035","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0404.2006.00716.x","article-title":"Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors","volume":"114","author":"Janghorbani","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.dsx.2016.12.042_bib0036","first-page":"240","article-title":"Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry","volume":"13","author":"Oguejiofor","year":"2010","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.dsx.2016.12.042_bib0037","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12955-014-0171-7","article-title":"The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes","volume":"12","author":"Dermanovic Dobrota","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.dsx.2016.12.042_bib0038","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-5491.2009.02784.x","article-title":"Smoking prevalence in type 2 diabetes: results of the study of health in pomerania (SHIP) and the german national health interview and examination survey (GNHIES)","volume":"26","author":"Schipf","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0039","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/17843286.1993.11718317","article-title":"Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes","volume":"48","author":"Scheen","year":"1993","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.dsx.2016.12.042_bib0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/dc09-0606","article-title":"Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy","volume":"33","author":"Wile","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1559-4564.2006.05513.x","article-title":"Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors","volume":"1","author":"Kabakov","year":"2006","journal-title":"J Cardiometab Syndr"},{"key":"10.1016\/j.dsx.2016.12.042_bib0042","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/dc05-2470","article-title":"Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes","volume":"29","author":"Eppens","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0043","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Mart\u00edn-Tim\u00f3n","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.dsx.2016.12.042_bib0044","doi-asserted-by":"crossref","first-page":"899","DOI":"10.12669\/pjms.294.3704","article-title":"Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes","volume":"29","author":"Ali","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.dsx.2016.12.042_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamainternmed.2013.12956","article-title":"Rates of complications and mortality in older diabetes patients: the diabetes and aging study","volume":"174","author":"Huang","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2016.12.042_bib0046","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1111\/j.1526-4637.2006.00179.x","article-title":"Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review","volume":"8","author":"Barrett","year":"2007","journal-title":"Pain Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0047","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/dc05-2228","article-title":"The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes","volume":"29","author":"Davies","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0048","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1185\/03007990903471940","article-title":"Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia","volume":"26","author":"Halawa","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.dsx.2016.12.042_bib0049","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/pgmj.2005.036137","article-title":"Diabetic neuropathy","volume":"82","author":"Bansal","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.dsx.2016.12.042_bib0050","doi-asserted-by":"crossref","first-page":"c1079","DOI":"10.1136\/bmj.c1079","article-title":"Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance","volume":"340","author":"Tan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.dsx.2016.12.042_bib0051","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.dsx.2016.12.042_bib0052","unstructured":"Standards of medical care in diabetes d 2015: summary of revisions, 38, 2015 (2015)."},{"key":"10.1016\/j.dsx.2016.12.042_bib0053","doi-asserted-by":"crossref","first-page":"730","DOI":"10.12669\/pjms.293.3473","article-title":"Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of International Working Group on Diabetic Foot (IWGDF)","volume":"29","author":"Shahbazian","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.dsx.2016.12.042_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmr.2007.10.010","article-title":"The spectrum of diabetic neuropathies","volume":"19","author":"Tracy","year":"2008","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.dsx.2016.12.042_bib0055","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/jnnp.50.10.1337","article-title":"Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion","volume":"50","author":"Bertelsmann","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.dsx.2016.12.042_bib0056","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.dsx.2016.12.042_bib0057","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0058","doi-asserted-by":"crossref","first-page":"g1799","DOI":"10.1136\/bmj.g1799","article-title":"Painful diabetic neuropathy","volume":"348","author":"Peltier","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.dsx.2016.12.042_bib0059","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2337\/diacare.15.4.528","article-title":"Microalbuminuria associated with diabetic neuropathy","volume":"15","author":"Bell","year":"1992","journal-title":"Diabetes Care"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2016.12.042_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1529-8027.2012.00390.x","article-title":"Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy","volume":"17","author":"Smith","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.dsx.2016.12.042_bib0061","first-page":"A114","article-title":"Control of risk factors among people with diagnosed diabetes, by lower extremity disease status","volume":"6","author":"Dorsey","year":"2009","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.dsx.2016.12.042_bib0062","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0063","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1464-5491.2004.01124.x","article-title":"Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes","volume":"21","author":"Costa","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2016.12.042_bib0064","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/dc06-0942","article-title":"The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from metascreen, a multicenter diabetes clinic-based survey","volume":"29","author":"Bonadonna","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.12.042_bib0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/2230-8210.81940","article-title":"Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy","volume":"15","author":"Al-Ani","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2016.12.042_bib0066","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1210\/jc.2010-0892","article-title":"The approach to the management of the patient with neuropathic pain","volume":"95","author":"Vinik","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2016.12.042_bib0067","unstructured":"C.E. Argoff, L.S. Kuritzky, P. George, Current treatments in the management of diabetic peripheral neuropathic pain (2009); 1-12."},{"key":"10.1016\/j.dsx.2016.12.042_bib0068","first-page":"166","article-title":"Pain associated with diabetic peripheral neuropathy: a review of available treatments","volume":"33","author":"St. Onge","year":"2008","journal-title":"Pharm Ther"},{"key":"10.1016\/j.dsx.2016.12.042_bib0069","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1161\/CIRCULATIONAHA.112.117333","article-title":"Body mass index and risk of incident hypertension over the life course: the Johns Hopkins Precursors Study","volume":"126","author":"Shihab","year":"2012","journal-title":"Circulation"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2016.12.042_bib0070","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2013the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes. Res"},{"key":"10.1016\/j.dsx.2016.12.042_bib0071","first-page":"296","article-title":"Peripheral insensate neuropathy-is height a risk factor?","volume":"7","author":"Kote","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.dsx.2016.12.042_bib0072","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clinthera.2011.02.007","article-title":"Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China","volume":"33","author":"Guan","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.dsx.2016.12.042_bib0073","first-page":"6","article-title":"Impact of diabetes education and peer support group on the metabolic parameters of patients with Diabetes Mellitus (Type 1 and Type 2)","volume":"6","author":"Sachmechi","year":"2013","journal-title":"Br J Med Pract"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402116302429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402116302429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:11:21Z","timestamp":1749852681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402116302429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":73,"alternative-id":["S1871402116302429"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2016.12.042","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic parameters in diabetic neuropathic patients after treatment with pregabalin","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2016.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}